Filter
274
Filtered Results: 274
Text search:
Australian
National
Clinical
Evidence
Taskforce
Featured
Recommendations
34
New Publications
51
Language
Document type
No document type
127
Studies & Reports
53
Guidelines
43
Manuals
26
Strategic & Response Plan
14
Training Material
6
Fact sheets
2
Situation Updates
1
Infographics
1
Online Courses
1
Countries / Regions
Global
20
India
17
Asia
6
Indonesia
5
Kenya
4
Western and Central Europe
4
Ukraine
3
Philippines
3
Africa
3
Nepal
2
Syria
2
Cambodia
2
Latin America and the Carribbean
2
Western Pacific Region
2
Jamaica
2
Bangladesh
2
Eastern Europe
2
Russia
2
Yemen
2
Myanmar / Burma
2
Thailand
1
Ghana
1
Sierra Leone
1
Kazakhstan
1
Laos
1
Estonia
1
Kyrgyzstan
1
Peru
1
Zimbabwe
1
Guinea
1
USA
1
Haiti
1
Lithuania
1
Tanzania
1
Middle East and North Africa
1
South Africa
1
Uganda
1
Brazil
1
Namibia
1
Ethiopia
1
Zambia
1
South Sudan
1
Liberia
1
Authors & Publishers
Publication Years
Category
Countries
46
Clinical Guidelines
40
Public Health
27
Women & Child Health
19
Key Resources
10
Capacity Building
5
Pharmacy & Technologies
5
Toolboxes
Mental Health
36
COVID-19
27
HIV
21
NCDs
18
Rapid Response
13
TB
13
Caregiver
11
AMR
10
Pharmacy
9
Disability
8
NTDs
7
Planetary Health
6
Global Health Education
5
Refugee
4
Conflict
3
Health Financing Toolbox
2
Natural Hazards
1
Ebola
1
Social Ethics
1
Zika
1
This publication is a compendium of 49 country examples highlighting efforts in improving refugees’ and migrants’ health following the adoption of the WHO Global Action Plan on Promoting the health of refugees and migrants at the seventy-second World Health Assembly, in May 2019.
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
Diabetes is a significant public health issue that affects approximately one in 10 adults globally, with type 2 diabetes accounting for 90–95% of cases. This chronic condition causes considerable morbidity and mortality and is growing in impact, with cases projected to rise from 537 million in 202...
The second edition of the joint WHO, WIPO and WTO
publication “Promoting Access to Medical Technologies
and Innovation: Intersections between public health,
intellectual property and trade” (the Trilateral Study),*
published in 2020, included a special insert mappi...
Guidelines on hepatitis B and C testing
recommended
Testing and diagnosis of hepatitis B (HBV) and C (HCV) infection is the gateway for access to both prevention and treatment services, and is a crucial component of an effective response to the hepatitis epidemic. Early identification of persons with chronic HBV or HCV infection enables them to recei...
The Western Pacific Regional Action Plan for the Prevention and Control of Noncommunicable Diseases (2014–2020) was developed in response to a resolution adopted at the sixty-second session of the WHO Regional Committee for the Western Pacific. The regional plan is fully harmonized with...
6 July 2021. The “WHO consolidated guidelines on tuberculosis. Module 3: Diagnosis - Rapid diagnostics for tuberculosis detection 2021 update” is the latest document replacing the one issued in 2020. Three new nucleic acid amplification test (NAAT) classes are endorsed by WHO and included in the...
Spanish version of "Developing Pharmacy Practice" - WHO/FIP Joint handbook -
Este manual de introducción marca un nuevo paradigma en la práctica de farmacia. Intenta guiar a los formadores en atención farmacéutica para educar a los estudiantes de farmacia y a los farmacéuticos ya estableci...
The World Health Organization Disability Assessment Schedule (WHODAS 2.0) is a generic assessment instrument developed by WHO to provide a standardized method for measuring health and disability across cultures. It was developed from a comprehensive set of International Classification of Functioning...
This manual summarizes the methodology used to develop WHODAS 2.0 and the findings obtained when the schedule was applied to certain areas of general health, including mental and neurological disorders.
The manual will be useful to any researcher or clinician wishing to use WHODAS 2.0 in their prac...
Social Determinants of Health Discussion Paper 1 (Debates). This paper was prepared for the launch of the Commission on Social Determinants of Health (CSDH) by its secretariat based at WHO in Geneva. It was discussed by the Commissioners and then revised considering their input.
